Sangui BioTech International Inc (SGBI):企業の財務・戦略的SWOT分析

◆英語タイトル:Sangui BioTech International Inc (SGBI) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C12808
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Sangui BioTech International Inc (SGBI) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sangui Biotech International Inc (Sangui Biotech), formerly Citadel Investment System, Inc, is a pharmaceutical company that develops novel and proprietary pharmaceuticals, medical products and cosmetics. Sangui Biotech’s product portfolio includes artificial oxygen carriers, nano formulations for the regeneration of skin, wound pads and wound spray. It also markets wound dressing products to support wound healing process in the name of chitoskin. The company develops oxygen carriers that can transport oxygen in acute and chronic conditions such as arterial blockage or anemia following injury, surgery, or other causes in humans. It markets the products in European countries, and Mexico through its subsidiary, and network of distribution partners. Sangui Biotech is headquartered in Witten, Nordrhein-Westfalen, Germany.

Sangui BioTech International Inc Key Recent Developments

Nov 15,2018: Sangui BioTech International: In the first three months of fiscal year 2019
Jul 25,2018: Sangui BioTech International: Financial Results for the year 2018
May 04,2018: Sangui BioTech International: fiscal year 2018 financial results
Jul 18,2017: Sangui Bio announces Revenues in fiscal year 2017
Feb 24,2017: Sangui Bio announces Sales in the first half year

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Sangui BioTech International Inc – Key Facts 5
Sangui BioTech International Inc – Key Employees 6
Sangui BioTech International Inc – Key Employee Biographies 7
Sangui BioTech International Inc – Major Products and Services 8
Sangui BioTech International Inc – History 9
Sangui BioTech International Inc – Company Statement 10
Sangui BioTech International Inc – Locations And Subsidiaries 11
Head Office 11
Other Locations & Subsidiaries 11
Section 2 – Company Analysis 12
Company Overview 12
Sangui BioTech International Inc – Business Description 13
R&D Overview 13
Sangui BioTech International Inc – Corporate Strategy 14
Sangui BioTech International Inc – SWOT Analysis 15
SWOT Analysis – Overview 15
Sangui BioTech International Inc – Strengths 15
Sangui BioTech International Inc – Weaknesses 16
Sangui BioTech International Inc – Opportunities 17
Sangui BioTech International Inc – Threats 18
Sangui BioTech International Inc – Key Competitors 19
Section 3 – Company Financial Ratios 20
Financial Ratios – Capital Market Ratios 20
Financial Ratios – Annual Ratios 21
Performance Chart 23
Financial Performance 23
Financial Ratios – Interim Ratios 24
Financial Ratios – Ratio Charts 25
Section 4 – Company’s Lifesciences Financial Deals and Alliances 26
Sangui BioTech International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26
Sangui BioTech International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27
Sangui BioTech International Inc, Recent Deals Summary 28
Section 5 – Company’s Recent Developments 29
Nov 15, 2018: Sangui BioTech International: In the first three months of fiscal year 2019 29
Jul 25, 2018: Sangui BioTech International: Financial Results for the year 2018 30
May 04, 2018: Sangui BioTech International: fiscal year 2018 financial results 31
Jul 18, 2017: Sangui Bio announces Revenues in fiscal year 2017 32
Feb 24, 2017: Sangui Bio announces Sales in the first half year 33
Jan 12, 2017: Sangui Bio announces Revenues in the first half-year 34
Section 6 – Appendix 35
Methodology 35
Ratio Definitions 35
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Sangui BioTech International Inc, Key Facts 5
Sangui BioTech International Inc, Key Employees 6
Sangui BioTech International Inc, Key Employee Biographies 7
Sangui BioTech International Inc, Major Products and Services 8
Sangui BioTech International Inc, History 9
Sangui BioTech International Inc, Subsidiaries 11
Sangui BioTech International Inc, Key Competitors 19
Sangui BioTech International Inc, Ratios based on current share price 20
Sangui BioTech International Inc, Annual Ratios 21
Sangui BioTech International Inc, Annual Ratios (Cont...1) 22
Sangui BioTech International Inc, Interim Ratios 24
Sangui BioTech International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26
Sangui BioTech International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27
Sangui BioTech International Inc, Recent Deals Summary 28
Currency Codes 35
Capital Market Ratios 35
Equity Ratios 36
Profitability Ratios 36
Cost Ratios 37
Liquidity Ratios 37
Leverage Ratios 38
Efficiency Ratios 38

List of Figures
Sangui BioTech International Inc, Performance Chart (2014 - 2018) 23
Sangui BioTech International Inc, Ratio Charts 25
Sangui BioTech International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26
Sangui BioTech International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 27

★海外企業調査レポート[Sangui BioTech International Inc (SGBI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Stantec Inc. (STN)(エネルギー分野):企業M&A動向
    Summary Stantec Inc. (Stantec) is a consulting services company, which offers services in the field of planning, engineering, consulting, architecture and interior design. The company’s portfolio of services include landscape architecture, surveying, environmental sciences, project management and pr …
  • DTEK Holdings Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' DTEK Holdings Limited Mergers a …
  • Hadasit Bio-Holdings Ltd (HDST):企業財務及び戦略的SWOT分析
    Summary Hadasit Bio-Holdings Ltd (Hadasit) is a biotechnology company that offers financing services. The company provides research and development, biotech financing, promoting and commercializing the intellectual property services in the biotechnology field. It funds the preparation and execution …
  • Tongaat Hulett Ltd (TON):企業の財務・戦略的SWOT分析
    Tongaat Hulett Ltd (TON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Galena Biopharma Inc (GALE):企業のM&A・提携動向(医療機器分野)
    Summary Galena Biopharma Inc (Galena) is a biotechnology company that discovers, develops and commercializes therapies for the treatment of unmet medical needs, and advance care. Its pipeline products include NeuVax, NeuVax Present, NeuVax Hercepti, NeuVax Vadis, GALE-401 (Anagrelide CR) and GALE-30 …
  • Venoco, LLC:企業のM&A・提携動向(石油・ガス分野)
    Summary Venoco, LLC (Venoco), formerly known as Venoco, Inc., is an independent energy company. It carries out acquisition, exploration, exploitation and development of oil and natural gas properties. The company’s major onshore and offshore properties are located in Southern California. Venoco offs …
  • PNE Wind AG (PNE3):企業の財務・戦略的SWOT分析
    PNE Wind AG (PNE3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Odebrecht S.A.:企業のM&A・提携動向(エネルギー分野)
    Summary Odebrecht S.A. (Odebrecht) is a diversified holding company, with key business interest in the fields of engineering, construction, chemicals and petrochemicals, defense, energy and transportation. The company provides engineering and construction services in transport, mining, sanitation, s …
  • Spinifex Pharmaceuticals Pty Limited(製薬・医療分野):企業M&A動向
    Summary Spinifex Pharmaceuticals Pty Ltd (Spinifex Pharma) is a biotechnology company. The company develops products for the treatment of pain. It develops EMA401 product for pain control. Spinifex Pharma’s EMA401 is a AT2 receptor antagonist which is used in the treatment of chronic pain. The compa …
  • Ubisoft Entertainment S.A.:企業の戦略・SWOT・財務情報
    Ubisoft Entertainment S.A. - Strategy, SWOT and Corporate Finance Report Summary Ubisoft Entertainment S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Zoosk, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Zoosk, Inc. Mergers and Acquisi …
  • Al Borg Laboratory SAE(製薬・医療分野):企業M&A動向
    Summary Al Borg Laboratory (Al Borg) is a provider of laboratory services. The company offers tests that predicts, diagnose and monitor disease. It conducts basic tests such as glucose testing for diabetes, and the complex molecular tests for hepatitis. The company provides over 2,000 tests covering …
  • American Electric Power Company, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' American Electric Power Company …
  • Dynavax Technologies Corp (DVAX):企業の財務・戦略的SWOT分析
    Dynavax Technologies Corp (DVAX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Coats Group plc:企業のM&A・提携・投資分析
    Coats Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Coats Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Winergy AG:企業の戦略的SWOT分析
    Winergy AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Molplex Ltd:企業のM&A・提携動向(医療分野)
    Summary Molplex Ltd (Molplex) is a pharmaceutical company that discovers and develops new medicines. The company offers development of therapeutic agents for the treatment of head and neck cancer, infectious mononucleosis, gram positive antibacterials, dengue and malaria fever and others. Molplex de …
  • Drax Group Plc:発電所・企業SWOT分析
    Drax Group Plc – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exe …
  • Dako AS-製薬・医療分野:企業M&A・提携分析
    Summary Dako A/S (Dako Denmark), a subsidiary of Agilent Technologies Inc is a diagnostic company. The company’s products include diagnostic antibodies, reagents and kits, software related products, instruments and related products, clone products, and synonym products. It also provides immunohistoc …
  • MannKind Corp (MNKD):製薬・医療:M&Aディール及び事業提携情報
    Summary MannKind Corp (MannKind) is a biopharmaceutical company that develops and commercializes inhaled therapeutic products for patients suffering from diabetes and pulmonary arterial hypertension. Its flagship product, Afrezza is a US FDA approved rapid-action inhaled insulin used to control high …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆